FundRx EpiBone Fund, a series of FundRx Master Fund I, LLC — Form D
FundRx EpiBone Fund, a series of FundRx Master Fund I, LLC of Salt Lake City, UT, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2016-12-01. The offering totals $70K, of which $70K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2016-12-01
- Form: D
- Accession: 0001683520-16-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $70K
- Amount sold: $70K
- Minimum investment: $20K
- Investors: 5
- Date of first sale: 2016-11-21
- Security types: fund interests
- SEC file number: 021-275420
Issuer
- Name: FundRx EpiBone Fund, a series of FundRx Master Fund I, LLC
- CIK: 0001683520
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2150 S 1300 E Suite 360, Salt Lake City, UT, 84106
- Phone: 8017133508
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
| Jens Beyrich | Executive Officer | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
More